期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 41, 期 3, 页码 863-872出版社
WILEY
DOI: 10.1002/eji.201040649
关键词
B lymphocytes; Cyclophosphamide; Lupus; Interferon-alpha; Short-lived plasma cells
类别
资金
- Baylor Health Care System Foundation
- Alliance for Lupus Research
- Center for Lupus Research [AR054083]
- NIH [AI068842]
IFN-alpha is known to play a critical role in the pathogenesis of systemic lupus erythematosus (SLE), but the mechanisms remain unclear. We previously showed that within weeks, exposure to IFN-alpha in vivo induces lupus in pre-autoimmune lupus-prone NZB x NZW F1 (NZB/W) but not in BALB/c mice. In the current study, we show that in vivo expression of IFN-alpha induces sustained B-cell proliferation in both BALB/c and NZB/W mice. In NZB/W but not BALB/c mice, B-cell proliferation was accompanied by a rapid and unabated production of autoantibody-secreting cells (ASCs) in secondary lymphoid organs, suggesting that a B-cell checkpoint is altered in the autoimmune background. The majority (> 95%) of ASCs elicited in IFN-alpha-treated NZB/W mice were short-lived and occurred without the induction of long-lived plasma cells. A short course of cyclophosphamide caused a sharp drop in IFN-alpha-elicited short-lived plasma cells, but the levels recovered within days following termination of treatment. Thus, our work provides new insights into effectiveness and limitations of the current SLE therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据